LINC01926

Across TCGA pan-cancer cohorts, LINC01926 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated LINC01926 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC01926 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC01926 expression acts as an unfavorable survival marker, although some lineages such as SKCM and LUAD show a favorable association.

SKCM, LUAD, and LUSC are the cancer types where LINC01926 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.455	0.296	<.001	94	view →
LUAD	DFS	Median	All	0.494	0.179	<.001	93	view →
LUSC	OS	Median	II,III,IV	0.492	0.716	<.001	70	view →
UVM	OS	Tertile	All	0.496	0.853	.004	54	view →
KIRC	OS	Tertile	All	0.534	0.672	.001	36	view →
OV	OS	Quartile	II,III,IV	0.404	0.301	.020	36	view →
LGG	OS	Tertile	All	0.551	0.814	<.001	27	view →
BLCA	OS	Tertile	II,III,IV	0.670	0.572	.025	26	view →
TGCT	OS	Tertile	III,IV	0.501	1.000	.014	18	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	18	view →
ACC	DFS	Tertile	IV	0.050	0.405	.016	9	view →
DLBC	DFS	Median	All	0.916	0.362	.016	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

LINC01926–SKCM (OS)

Open the SKCM breakdown →